UPS is continuing to increase its presence in the Chinese healthcare sector, creating a new position dedicated to the regional supply chain and adding additional resources in the area. Bernard Jiang, who is the new China supply chain and healthcare logistics director, will manage the company’s China network, direct supply chain solutions and oversee warehousing, among other duties.
“The strengthening of UPS’s supply chain and healthcare practice in China gives UPS customers the ability to have more visibility and control over their entire supply chain. Adding additional supply chain resources will support our customers as they enter or expand their operations in China, within Asia or globally,” said Foster. “This is a continued extension of UPS Asia Pacific contract logistics support that has seen global and local companies through many successful years in their Asia Pacific growth.”
Healthcare growth, in particular, is a central tenet of UPS’s plans moving forward, whether in Asia or elsewhere around the world. In May, after celebrating a successful shipment of flu vaccines from Kentucky to Laos, UPS’s Mark Davis told Air Cargo World that pharmaceutical shipments are a major focus for UPS. The integrator opened five pharmaceutical facilities last year in the Americas, Europe and Asia, and as UPS’s recent actions in China show, the company doesn’t intend to slow down soon.
“We are investing in the segment to ensure we have the infrastructure necessary to not only manage the transportation of healthcare and pharmaceutical product, but also to continue to build upon the 30-plus dedicated healthcare distribution facilities UPS currently has operating around the world,” he told Air Cargo World in May.
He also said UPS sees healthcare as an area where it can maximize its knowledge of brokerage, regulatory compliance, distribution and post-sales, order-to-cash services and heavy freight transportation of all modes. “And all of these areas are backed by our technology,” Davis said.